Reuters logo
BRIEF-Syndax Pharmaceuticals, National Cancer Institute collaborate to develop cancer treatments
December 14, 2016 / 12:17 PM / a year ago

BRIEF-Syndax Pharmaceuticals, National Cancer Institute collaborate to develop cancer treatments

Dec 14 (Reuters) - Syndax Pharmaceuticals Inc

* Syndax Pharmaceuticals announces collaboration with the National Cancer Institute to develop entinostat and SNDX-6352 for the treatment of cancer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below